title: Renal transplantation under FK 506 in patients with previous loss of renal function due to hemolytic uremic syndrome.
authors.affiliation: Department of Medicine, University of Pittsburgh School of Medicine, Presbyterian-University Hospital, PA 15213.
authors.forename: J
authors.initials: J
authors.lastname: McCauley
authors.forename: R
authors.initials: R
authors.lastname: Shapiro
authors.forename: O
authors.initials: O
authors.lastname: Bronster
authors.forename: M
authors.initials: M
authors.lastname: Jordan
authors.forename: D
authors.initials: D
authors.lastname: Ellis
authors.forename: N
authors.initials: N
authors.lastname: Gilboa
authors.forename: V
authors.initials: V
authors.lastname: Scantlebury
authors.forename: C
authors.initials: C
authors.lastname: Jensen
authors.forename: A
authors.initials: A
authors.lastname: Jain
authors.forename: T
authors.initials: T
authors.lastname: Starzl
mesh_terms: D000328:Adult; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000139:chemically induced / Q000503:physiopathology / Q000601:surgery*; D006801:Humans; D007223:Infant; D007668:Kidney / Q000503:physiopathology; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000139:chemically induced; D016896:Treatment Outcome
chemical_list: D016572:Cyclosporine; D016559:Tacrolimus